Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | UTS2R | Q9UKP6 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 3/20 | 0.45 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | PHGDH | O43175 | 1/20 | 0.42 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14224487 | 0.85 | MAPK1 (0.49) | KMT2AALDH1A1LMNASMN1; SMN2RIPK1 | |
| SCHEMBL25196651 | 0.85 | ALDH1A1 (0.55) | KMT2AALDH1A1LMNASMN1; SMN2UTS2R | |
| SCHEMBL31037004 | 0.83 | SLC6A9 (0.47) | KMT2AALDH1A1LMNASMN1; SMN2CNR2 | |
| SCHEMBL14224547 | 0.83 | RIPK1 (0.62) | ALDH1A1LMNASMN1; SMN2RIPK1HTT | |
| SCHEMBL14224491 | 0.83 | RIPK1 (0.62) | ALDH1A1LMNASMN1; SMN2RIPK1HTT | |
| SCHEMBL29751787 | 0.83 | MAPK1 (0.46) | KMT2AALDH1A1RIPK1PHGDHMEN1 | |
| SCHEMBL16901655 | 0.83 | MAPK1 (0.46) | KMT2AALDH1A1RIPK1PHGDHMEN1 | |
| SCHEMBL31037006 | 0.83 | MAPK1 (0.46) | KMT2AALDH1A1RIPK1PHGDHMEN1 | |
| SCHEMBL14224656 | 0.82 | TSHR (0.54) | — | |
| SCHEMBL14224493 | 0.82 | TSHR (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7354919-B2 | Isoxazole compositions useful as inhibitors of ERK | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-04-08 | — | — | US | disclosed |